Article Information
History
- June 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Paloma Martín-Jiménez1,*,
- Mariana I. Muñoz-García1,*,
- David Seoane1,*,
- Lucas Roca-Rodríguez1,*,
- Ana García-Reyne2,
- Antonio Lalueza2,3,5,
- Guillermo Maestro2,
- Dolores Folgueira3,4,
- Víctor A. Blanco-Palmero1,5,6,
- Alejandro Herrero-San Martín1,5,6,
- Sara Llamas-Velasco1,5,6,
- David A. Pérez-Martínez1,3,5,6,
- Marta González-Sánchez1,5,6,¶ and
- Alberto Villarejo-Galende1,3,5,6,¶
- 1Department of Neurology. Hospital Universitario 12 de Octubre. Madrid. Spain
- 2Department of Internal Medicine. Hospital Universitario 12 de Octubre. Madrid. Spain
- 3Department of Medicine. School of Medicine, Complutense University, Madrid, Spain
- 4Department of Microbiology. Hospital Universitario 12 de Octubre. Madrid. Spain
- 5Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (I+12). Madrid, Spain
- 6Biomedical Research Networking Center in Neurodegenerative diseases (CIBERNED), Madrid, Spain
- ↵¶Corresponding authors. Contributed equally to this work. Address correspondence to Dr. Alberto Villarejo Galende, Servicio de Neurología, Hospital Universitario 12 de Octubre. C/ Andalucía, Km 5,4. E-28041 Madrid, Spain., Fax: 0034 913908600, e-mail: avgalende{at}yahoo.es; martags.86{at}gmail.com.
↵* These authors contributed equally to this work.
Posted June 09, 2020.
Cognitive impairment is a common comorbidity in COVID-19 deceased patients. A hospital-based retrospective cohort study
